ONCC oncology nursing certification EXAM A+ GRADE ASSURED COMPLETE SOLUTIONS AND VERIFIED ANSWERS

EXAM

Exam Solution vc




ONS ONCC Chemo Renewal Oncology Exams 2026 A+ GR
vc vc vc vc vc vc vc vc




ADE ASSURED COMPLETE SOLUTIONS AND VERIFIED A
vc vc vc vc vc vc




NSWERS (79462) vc




QUESTION 1 vc




Main benefit of neoadjuvant chemotherapy (breast cancer patient)
vc vc vc vc vc vc vc




ANSWER

Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It only changes th
vc vc vc vc vc vc vc vc vc vc vc vc vc vc



e timing of treatment and can change surgical options if the tumor is shrunk enough. If this occurs, the
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



patient may only require a lumpectomy plus radiation therapy instead of needing a mastectomy
vc vc vc vc vc vc vc vc vc vc vc vc vc




QUESTION 2 vc




Due to Mrs. Turner's age and comorbidities, her oncologist performs a comprehensive ge
vc vc vc vc vc vc vc vc vc vc vc vc



riatric assessment. You know that this assessment covers all but which of the following:
vc vc vc vc vc vc vc vc vc vc vc vc vc




ANSWER

A comprehensive geriatric assessment (CGA) is a multidisciplinary evaluation to assess life expectancy a
vc vc vc vc vc vc vc vc vc vc vc vc vc



nd risk of morbidity and mortality in the older patient. This assessment tool would evaluate and include
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



the following areas: functional status, socioeconomic issues, psychosocial distress, comorbidities, cognit
vc vc vc vc vc vc vc vc vc vc vc



ive function, nutritional status, polypharmacy, and a medication review (NCCN Older Adult Oncology Gui
vc vc vc vc vc vc vc vc vc vc vc vc vc



delines, version 1.2015). vc vc




QUESTION 3 vc




The NCCN Older Adult Oncology Guidelines (version 1.2015) provides information on wh
vc vc vc vc vc vc vc vc vc vc vc



at is included in a comprehensive geriatric assessment. Currently, more than 60% of can
vc vc vc vc vc vc vc vc vc vc vc vc vc



cers in the United States occur in people age ______and older and as the oncology world ag
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



es, nearly half (46%) of cancer survivors are 70 years of age or older
vc vc vc vc vc vc vc vc vc vc vc vc vc




ANSWER

65

, QUESTION 4 vc




What is your best explanation for why Mrs. Turner was given a port to receive her chem
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



otherapy?
ANSWER

Two of the agents (docetaxel and carboplatin) that Mrs. Turner will receive are categorized as irritants.
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



Docetaxel can cause a significant reaction if it extravasates. It can lead to edema, erythema, occasional p
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



ain and blister formation (ONS Chemo/Bio guidelines, 2014). That is the most likely reason that Mrs. Tu
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



rner was given a port for her treatments. Some patients will receive their treatments through a peripher
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



al IV without incident. Just because they are intravenous agents does not mean that a port is required a
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



nd needing a port has nothing to do with her being older in age. Since none of these agents are vesicant
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



s, they likely could have been given safely via peripheral route but having a port placed is OK as well.
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc




QUESTION 5 vc




_____________can cause inflammation, pain, and burning but rarely cause tissue necrosis co
vc vc vc vc vc vc vc vc vc vc vc



mparable to a vesicant (unless a large amount or a very high concentration of the irritan
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



t is extravasated).
vc vc




ANSWER

Irrirtants



QUESTION 6 vc




_____________can cause blistering and significant pain and tissue damage and destruction, le
vc vc vc vc vc vc vc vc vc vc vc



ading to tissue death. vc vc vc




ANSWER

Vesicants



QUESTION 7 vc




A further classification of an antineoplastic agent's potential to cause damage is whether
vc vc vc vc vc vc vc vc vc vc vc vc vc



its mechanism of action includes DNA binding.
vc vc vc vc vc vc




ANSWER

Non-DNA-
binding solutions remain in the local area of the extravasation, which improves the possibility of drug d
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



eactivation. DNA- vc



binding agents attach to DNA nucleic acids, causing the antagonist to be ingested cellularly, leading to pr
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



ogressive tissue destruction vc vc